P53 mutations in egyptian bladder-cancer

Area of Science:

• Oncology
• Molecular Biology
• Parasitology

Background:

• Bladder cancer is prevalent in Egypt, often linked to Schistosoma haematobium infection.
• Bilharzial bladder cancer exhibits distinct characteristics compared to that in industrialized nations.
• Molecular alterations in Egyptian bladder cancer remain understudied.

Purpose of the Study:

• To investigate the status of the p53 gene in Egyptian bladder cancer.
• To correlate p53 gene mutations with clinical and histopathological features.
• To evaluate the utility of immunohistochemistry in detecting p53 mutations.

Main Methods:

• Studied 25 Egyptian bladder cancer cases.
• Utilized immunohistochemistry for p53 protein detection.
• Employed SSCP/sequencing to identify p53 gene mutations.

Main Results:

• p53 gene mutations detected in 40% (10/25) of tumor samples.
• Mutations occurred in both squamous and transitional cell variants.
• p53 mutations were associated with advanced disease stage.
• Immunohistochemistry showed 70% sensitivity and 85% specificity for mutation detection.

Conclusions:

• p53 gene mutations are frequent in Egyptian bladder cancer and may indicate advanced disease.
• Immunohistochemistry is a reliable method for detecting p53 mutations in this context.
• Further assessment of p53 mutations' prognostic value is warranted.